Obesity as a risk factor for nonalcoholic fatty liver disease. Approaches to correction of overweight and obesity
Obesity is considered to be a major factor for non-alcoholic fatty liver disease. Approaches for the treatment of obesity are discussed, in particular, the effectiveness of biologically active food supplement Hepaguard Active, a complex containing L-carnitine, is evaluated.
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2014-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/771 |